Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 18/20 | 0.76 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7953715 | 0.92 | PLA2G2A (0.76) | PLA2G2APLA2G1BPTGS2TSHRMAPK1 | |
| SCHEMBL8301133 | 0.88 | PLA2G2A (0.75) | PLA2G2APLA2G1BTSHRMAPK1KMT2A | |
| SCHEMBL7953548 | 0.86 | PLA2G2A (1.00) | PLA2G2APLA2G1B | |
| SCHEMBL8296297 | 0.86 | PLA2G2A (0.76) | PLA2G2APLA2G1B | |
| SCHEMBL9095989 | 0.84 | PLA2G2A (0.57) | PLA2G2APLA2G1B | |
| SCHEMBL8293050 | 0.83 | PLA2G2A (1.00) | PLA2G2A | |
| SCHEMBL7962081 | 0.81 | PLA2G2A (0.80) | PLA2G2APLA2G1BPTGS2TSHRMAPK1 | |
| SCHEMBL7965802 | 0.79 | PLA2G2A (0.70) | PLA2G2APLA2G1BPTGS2TSHRMAPK1 | |
| SCHEMBL8647358 | 0.79 | LMNA (0.77) | PLA2G2APLA2G1BPTGS2TSHRMAPK1 | |
| SCHEMBL8290865 | 0.79 | PLA2G2A (0.74) | PLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6252084-B1 | THERAPY FOR SEPSIS SHOCK | ELI LILLY AND COMPANY | 2001-06-26 | — | — | US | disclosed |
| EP-0620215-B1 | 1H-indole-3-acetamide derivatives as sPLA2 inhibitors | LILLY CO ELI (US) | 1999-08-18 | — | — | EP | disclosed |
| EP-0620214-B1 | 1H-indole-3-acetic acid hydrazide sPLA2 inhibitors | LILLY CO ELI (US) | 1999-03-03 | — | — | EP | disclosed |
| US-5684034-A | INHIBITORS OF HUMAN NON-PANCREATIC SECRETORY PHOSPHOLIPASE A2, TREATMENT OF SEPTIC SHOCK, TRAUMA, RESPIRATORY DISORDERS, RHEUMATIC ARTHRITIS, INHIBITORS OF ARACHIDONIC ACID RELEASE | ELI LILLY AND COMPANY (US) | 1997-11-04 | — | — | US | disclosed |
| US-5578634-A | SEPTIC SHOCK TREATMENT | ELI LILLY AND COMPANY (US) | 1996-11-26 | — | — | US | disclosed |
| EP-0620215-A1 | 1H-indole-3-acetamide derivatives as sPLA2 inhibitors | ELI LILLY AND COMPANY (US) | 1994-10-19 | — | — | EP | disclosed |
| EP-0620214-A1 | 1H-indole-3-acetic acid hydrazide sPLA2 inhibitors | ELI LILLY AND COMPANY (US) | 1994-10-19 | — | — | EP | disclosed |